SUBSEQUENT EVENTS (Detail Textuals) - USD ($) |
Mar. 05, 2021 |
Mar. 04, 2021 |
Mar. 03, 2021 |
Feb. 28, 2021 |
|---|---|---|---|---|
| Subsequent Event [Line Items] | ||||
| Number of options exercisable | 237,237 | |||
| Subsequent event | Stock Options | ||||
| Subsequent Event [Line Items] | ||||
| Number of shares issued during period | 920,000 | 30,000 | ||
| Vesting period of stock option | 3 years | |||
| Expiration date under plan | Mar. 05, 2031 | |||
| Weighted-average exercise price | $ 0.75 | $ 1.52 | ||
| Proceeds from stock plans | $ 690,000 | |||
| Number of options exercisable | 920,000 | |||
| Subsequent event | Stock Options | Chief Executive Officer and President | ||||
| Subsequent Event [Line Items] | ||||
| Expiration date under plan | Mar. 05, 2031 | |||
| Description of vesting term | twenty-five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the grant date, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter on the same day of the month as the grant date, subject to the Chief Executive Officer’s continued service to the Company | |||
| Exercise price | $ 1.52 | |||
| Number of shares grant to purchase common stock | 575,100 |
| X | ||||||||||
- Definition The cash inflow associated with the amount received from the stock plan during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Date the equity-based award expires, in CCYY-MM-DD format. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share weighted-average price paid for shares purchased on open market for issuance under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares issued under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Description of terms of award under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|